Recent Patent Reform Bills and Their Implications for Prescription Drugs

This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2023-02, Vol.329 (6), p.459-460
Main Authors: Tu, S. Sean, Nagar, Sarosh, Kesselheim, Aaron S
Format: Article
Language:English
Subjects:
Clinical medicine
Fraud
Health Care Reform - legislation & jurisprudence
Legislation, Drug
Patents as Topic - legislation & jurisprudence
Prescription Drugs
United States
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Viewpoint discusses 3 bills introduced recently in Congress that focus on patent eligibility, fraud, and quality and that have major implications for clinical medicine and pharmaceutical development.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2022.24983